Search research articles
Contact Us
Filters
Showing results (301-310 of 364) with videos related to
Page
of 37
Sort By:
BMC Gastroenterology
|
January 18, 2013
The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
Jan G D'Haese, Ihsan Ekin Demir, Timo Kehl, et al.
Der Internist
|
February 14, 2016
[Recurrent hypoglycemia due to an occult insulinoma]
T G K Breuer, H L Breuer, B A Menge, et al.
International Journal of Cancer
|
July 17, 2007
Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer
Michael W Müller, Nathalia A Giese, Jakub M Swiercz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 21, 2009
Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis
Güralp O Ceyhan, Stefanie Deucker, Ihsan Ekin Demir, et al.
Plos One
|
August 11, 2011
Prognostic significance of erythropoietin in pancreatic adenocarcinoma
Thilo Welsch, Stefanie Zschäbitz, Verena Becker, et al.
Gut
|
September 22, 2005
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
M Hartel, F F di Mola, F Selvaggi, et al.
Nature Medicine
|
October 20, 2015
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
Muhammad S Alam, Matthias M Gaida, Frank Bergmann, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18
Andrew S Wagner, Frances M Smith, David A Bennin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 9, 1999
The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates
N A Giese, M M Marijianowski, O McCook, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury
J C Yu, N A Lokker, S Hollenbach, et al.
Page
of 37
Search research articles
Search
Showing results (301-310 of 364) with videos related to
Sort By:
Page
of 37
BMC Gastroenterology
|
January 18, 2013
The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
Jan G D'Haese, Ihsan Ekin Demir, Timo Kehl, et al.
Der Internist
|
February 14, 2016
[Recurrent hypoglycemia due to an occult insulinoma]
T G K Breuer, H L Breuer, B A Menge, et al.
International Journal of Cancer
|
July 17, 2007
Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer
Michael W Müller, Nathalia A Giese, Jakub M Swiercz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 21, 2009
Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis
Güralp O Ceyhan, Stefanie Deucker, Ihsan Ekin Demir, et al.
Plos One
|
August 11, 2011
Prognostic significance of erythropoietin in pancreatic adenocarcinoma
Thilo Welsch, Stefanie Zschäbitz, Verena Becker, et al.
Gut
|
September 22, 2005
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
M Hartel, F F di Mola, F Selvaggi, et al.
Nature Medicine
|
October 20, 2015
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
Muhammad S Alam, Matthias M Gaida, Frank Bergmann, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18
Andrew S Wagner, Frances M Smith, David A Bennin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 9, 1999
The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates
N A Giese, M M Marijianowski, O McCook, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury
J C Yu, N A Lokker, S Hollenbach, et al.
Page
of 37